Dr. Graziano  Riccioni

Dr. Graziano Riccioni

Medical Professional/Doctor
University of Chieti, Italy


Highest Degree
Ph.D. in Biomedical Sciences from University of Chieti, Italy

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Allergy
62%
Immunopathology
90%
Pharmacology
75%
Inflammation
55%

Selected Publications

  1. Riccioni, G., L. Speranza, M. Pesce, S. Cusenza, N. D'Orazio and M.J. Glade, 2012. Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition, 28: 605-610.
    CrossRef  |  Direct Link  |  

  2. Riccioni, G., 2012. Marine carotenoids and oxidative stress. Marine Drugs, 10: 116-118.

  3. Speranza, L., S. Franceschelli, N. D'Orazio, R. Gaeta and T. Bucciarelli et al., 2011. The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure. Microvasc. Res., 82: 391-396.
    CrossRef  |  Direct Link  |  

  4. Riccioni, G., V. Bucciarelli, E. Di Ilio, L. Scotti and A. Aceto et al., 2011. Recurrent atrial fibrillation in a patient with ulcerative colitis treated with azathioprine: Case report and review of the literature. Int. J. Immunopathol. Pharmacol., 24: 247-249.
    PubMed  |  

  5. Riccioni, G., N. D'Orazio, S. Franceschelli and L. Speranza, 2011. Marine carotenoids and cardiovascular risk markers. Marine Drugs, 9: 1166-1175.

  6. Riccioni, G., L. Speranza, L. Scotti, V. Bucciarelli and E. Di Ilio et al., 2011. The effect of pharmacological treatment on ADMA in patients with heart failure. Front. Biosci., 3: 1310-1314.

  7. Riccioni, G., L. Scotti, E. Di Ilio, V. Bucciarelli and E. Ballone et al., 2011. Lycopene and preclinical carotid atherosclerosis. J. Biol. Regul. Homeost. Agents, 25: 435-441.

  8. Riccioni, G., F. Cipollone, D. Santovito, L. Scotti, N. D'Orazio, A. Mezzetti and T. Bucciarelli, 2011. Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease. Expert Opin. Pharmacother., 12: 2599-2604.
    CrossRef  |  Direct Link  |  

  9. Riccioni, G., 2011. Ivabradine: Recent and potential applications in clinical practice. Expert Opin. Pharmacother., 12: 443-450.
    CrossRef  |  

  10. Riccioni, G., 2011. Aliskiren in the treatment of hypertension and organ damage. Cardiovas. Therap., 29: 77-87.
    CrossRef  |  Direct Link  |  

  11. Franceschelli, S., M. Pesce, I. Vinciguerra, A. Ferrone and G. Riccioni et al., 2011. Licocalchone-C extracted from Glycyrrhiza Glabra inhibits lipopolysaccharide-interferon-γ inflammation by improving antioxidant conditions and regulating inducible nitric oxide synthase expression. Molecules, 16: 5720-5734.
    CrossRef  |  Direct Link  |  

  12. Riccioni, G., V. Bucciarelli, L. Scotti, A. Aceto, N. D'Orazio, E. Di Ilio and T. Bucciarelli, 2010. Relationship between asymmetric dimethylarginine and asymptomatic carotid atherosclerosis. J. Biol. Regul. Homeostatic Agents, 24: 351-358.

  13. Riccioni, G., N. Vitulano, B. Mancini, A. Zanasi and N. D'Orazio, 2010. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease. Pharmacology, 85: 63-67.
    CrossRef  |  Direct Link  |  

  14. Riccioni, G., N. Vitulano, A. Zanasi, F. Bellocci and N. D'Orazio, 2010. Aliskiren: Beyond blood pressure reduction. Expert Opin. Invest. Drugs, 19: 1265-1274.
    CrossRef  |  Direct Link  |  

  15. Riccioni, G., N. D'Orazio, L. Scotti, R. Petruzzelli and A. Latino et al., 2010. Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: A case control study. Int. J. Immunopathol. Pharmacol., 23: 327-334.

  16. Riccioni, G., M. Back and V. Capra, 2010. Leukotrienes and atherosclerosis. Curr. Drug Targets, 11: 882-887.
    Direct Link  |  

  17. Riccioni, G., A. Zanasi, N. Vitulano, B. Mancini and N. D'Orazio,2010 2010. Leukotrienes in atherosclerosis: New target insights and future therapy perspectives. Mediators Inflamm., Vol. 2009 10.1155/2009/737282.
    CrossRef  |  

  18. Riccioni, G., 2010. Ivabradine: From molecular basis to clinical effectiveness. Adv. Ther., 27: 160-167.
    CrossRef  |  

  19. Riccioni, G., N. Vitulano, N. D'Orazio and F. Bellocci, 2009. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension. Adv. Ther., 26: 700-710.
    CrossRef  |  Direct Link  |  

  20. Riccioni, G., N. Vitulano and N. D'Orazio, 2009. Ivabradine: Beyond heart rate control. Adv. Ther., 26: 12-24.
    CrossRef  |  Direct Link  |  

  21. Riccioni, G., N. D'Orazio, N. Palumbo, V. Bucciarelli, E. di Ilio, L.A. Bazzano and T. Bucciarelli, 2009. Relationship between plasma antioxidant concentrations and carotid intima-media thickness: The asymptomatic carotid atherosclerotic disease in manfredonia study. Eur. J. Cardiovasc. Preven. Rehabil., 16: 351-357.
    CrossRef  |  Direct Link  |  

  22. Riccioni, G., 2009. The effect of antihypertensive drugs on carotid intima media thickness: An up-to-date review. Curr. Med. Chem., 16: 988-996.
    Direct Link  |  

  23. Riccioni, G., 2009. Statins and carotid intima-media thickness reduction: An up-to-date review. Curr. Med. Chem., 16: 1799-1805.
    Direct Link  |  

  24. Riccioni, G., 2009. Focus on ivabradine: A new heart rate-controlling drug. Expert Rev. Cardiovasc. Ther., 7: 107-113.
    CrossRef  |  Direct Link  |  

  25. Riccioni, G., 2009. Carotenoids and cardiovascular disease. Curr. Atheroscler. Rep., 11: 434-439.
    CrossRef  |  Direct Link  |  

  26. Riccioni, G., V. Capra, N. D'Orazio, T. Bucciarelli and L.A. Bazzano, 2008. Leukotriene modifiers in the treatment of cardiovascular diseases. J. Leukocyte Biol., 84: 1374-1378.
    CrossRef  |  Direct Link  |  

  27. Riccioni, G., T. Bucciarelli, N. D'Orazio, N. Palumbo and E. Di Ilio et al., 2008. Plasma antioxidants and asymptomatic carotid atherosclerotic disease. Ann. Nutr. Metab., 53: 86-90.
    CrossRef  |  Direct Link  |  

  28. Riccioni, G., L.A. Bazzano, T. Bucciarelli, B. Mancini, E. Di Ilio and N. D'Orazio, 2008. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: The Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study. Expert Opin. Pharmacother., 9: 2403-2408.
    CrossRef  |  Direct Link  |  

  29. Riccioni, G., B. Mancini, E. Di Ilio, T. Bucciarelli and N. D'Orazio, 2008. Protective effect of lycopene in cardiovascular disease. Eur. Rev. Med. Pharmacol. Sci., 12: 183-190.
    Direct Link  |  

  30. Riccioni, G. and L.A. Bazzano, 2008. Antioxidant plasma concentration and supplementation in carotid intima media thickness. Expert Rev. Cardiovasc. Ther., 6: 723-729.
    CrossRef  |  

  31. Sblendorio, V., B. Palmieri and G. Riccioni, 2007. Blood cholesterol concentration measured by CR3000: Fingerstick versus venous sampling. Int. J. Immunopathol. Pharmacol., 21: 729-733.
    Direct Link  |  

  32. Riccioni, G., T. Bucciarelli, B. Mancini, F. Corradi, C. Di Ilio, P.A. Mattei and N. D'Orazio, 2007. Antioxidant vitamin supplementation in cardiovascular diseases. Ann. Clin. Lab. Sci., 37: 89-95.
    Direct Link  |  

  33. Riccioni, G., T. Bucciarelli, B. Mancini, E. di Ilio and G. Palumbo et al., 2007. Compliance therapy with Anti-inflammatory antiasthmatic drugs: Inhaled corticosteroids and leukotriene receptor antagonists. Clinica Ter., 158: 363-370.
    PubMed  |  

  34. Riccioni, G., T. Bucciarelli, B. Mancini, C.D. Ilio, R.D. Vecchia and N. D'Orazio, 2007. Plasma lycopene and antioxidant vitamins in asthma: The PLAVA study. J. Asthma, 44: 429-432.
    CrossRef  |  Direct Link  |  

  35. Riccioni, G., T. Bucciarelli, B. Mancini, C. di Ilio and N. D'Orazio, 2007. Antileukotriene drugs: Clinical application, effectiveness and safety. Curr. Med. Chem., 14: 1966-1977.
    CrossRef  |  Direct Link  |  

  36. Riccioni, G., T. Bucciarelli, B. Mancini, C. Di Ilio, V. Capra and N. D'Orazio, 2007. The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert Opin. Invest. Drugs, 16: 25-32.
    CrossRef  |  Direct Link  |  

  37. Riccioni, G., M. Barbara, T. Bucciarelli, C. di Ilio and N. D'Orazio, 2007. Antioxidant vitamin supplementation in asthma. Ann. Clin. Lab. Sci., 37: 96-101.
    Direct Link  |  

  38. Riccioni, G., 2007. Integrated control of hypertension, dyslipidemia and carotid atherosclerosis in the reduction of cardiovascular risk. Exp. Rev. Cardiovasc Ther., 5: 371-374.
    PubMed  |  

  39. Riccioni, G. and N. D'Orazio, 2007. Reduction of intima-media thickness in subjects with asymptomatic carotid disease: Two cases from the Asymptomatic Carotid Atherosclerosis DIsease Manfredonia Study (ACADIM Study). Clin. Terap., 158: 431-433.
    PubMed  |  

  40. Castellani, M.L., Y.B. Shaik, L.N. Shanmugham, S. Frydas and B. Madhappan et al., 2007. Role of flavonoids and vitamins in cancer. Rivista Biol., 100: 39-54.
    PubMed  |  

  41. Riccioni, G., T. Bucciarelli, C. di Ilio, F. Corradi and R. Della Vecchia et al., 2006. Is nasal polyposis a determinant of bronchial hyperresponsiveness and altered quality of life in asthmatic subjects? A case-control study. Ann. Clin. Lab. Sci., 36: 170-173.
    Direct Link  |  

  42. Riccioni, G., T. Bucciarelli, B. Mancini, C. di Ilio and N. D'Orazio, 2006. Plasma lycopene concentration is low in subjects with stable asthma. Allergy, 61: 1371-1372.
    CrossRef  |  

  43. Riccioni, G., B. Mancini, T. Bucciarelli, C. Di Ilio and N. D'Orazio, 2006. Role of anti-oxidants in the treatment of bronchial asthma. Drug Discovery Today, 3: 293-298.
    CrossRef  |  

  44. Capra, V., M. Ambrosio, G. Riccioni and G.E. Rovati, 2006. Cysteinyl-leukotriene receptor antagonists: Present situation and future opportunities. Curr. Med. Chem., 13: 3213-3226.
    Direct Link  |  

  45. Riccioni, G., V. di Pietro, T. Staniscia, L. de Feudis and G. Traisci et al., 2005. Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. Int. J. Immunopathol. Pharmacol., 18: 575-586.
    PubMed  |  

  46. Riccioni, G., M. de Benedictis, R. Della Vecchia, C. di Ilio, M.T. Guagnano and N. D'Orazio, 2005. Prevalence and severity of the airway obstruction degree in an Italian adult population: Result of One-year observational study. Mon. Arch. Chest Dis., 63: 88-92.

  47. Riccioni, G. And N. D'Orazio, 2005. The role of selenium, zinc and antioxidant vitamin supplementation in the treatment of bronchial asthma: Adjuvant therapy or not? Exp. Opin. Invest. Drugs, 14: 1145-1155.
    CrossRef  |  Direct Link  |  

  48. Frydas, S., N. Papaioannou, M. Papazahariadou, M. Hatzistilianou and E. Karagouni et al., 2005. Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: Effect of the Anti-inflammatory compound L-mimosine. Int. J. Immunopathol. Pharmacol., 18: 85-94.
    PubMed  |  

  49. Riccioni, G., V. Menna, M.S. Lambo, R. Della Vecchia, C. di Ilio, A. de Lorenzo and N. D'Orazio, 2004. Leptin and hypothalamus-hypophysis-thyroid axis. Clin. Terapeutica, 155: 29-31.
    PubMed  |  

  50. Riccioni, G., V. Menna, F. Filippakos, C. di Ilio and G. di Tano et al., 2004. Interaction connecting Leptin-obesity-insulin dependent diabetes mellitus. Eur. J. Inflammation, 2: 17-20.

  51. Riccioni, G., V. Menna, C. di Ilio and N. D'Orazio, 2004. Food-intake and nutrients pattern in Italian adult male subjects. Clin. Ter., 155: 283-286.
    PubMed  |  

  52. Riccioni, G., R. Della Vecchia, V. Menna, T. Staniscia, C. di Ilio, P. Conti and N. D'Orazio, 2004. Irritable bowel syndrome and bronchial hyperresponsiveness: Is there a link? Digestion, 69: 185-189.
    CrossRef  |  Direct Link  |  

  53. Riccioni, G., R. Della Vecchia, V. Menna, C. Di Ilio, P. Conti and N. D'Orazio, 2004. Prevalence of bronchial asthma in patients with Endoscopically-documented esophagitis. Ann. Clin. Lab. Sci., 34: 94-98.
    PubMed  |  

  54. Riccioni, G., R. Della Vecchia, F. Romano, T. Staniscia and N. Verna et al., 2004. Interrelationship between asthma and functional bowel disease. Eur. J. Infl., 3: 125-128.

  55. Riccioni, G., R. Della Vecchia, C. di Ilio and N. D'Orazio, 2004. Effect of the two different leukotriene receptor antagonists montelukast and zafirlukast on quality of life: A 12-week randomized study. Allergy Asthma Proc., 25: 445-448.
    Direct Link  |  

  56. Riccioni, G., N. D'Orazio, C. di Ilio, V. Menna, M.T. Guagnano and R. Della Vecchia, 2004. Quality of life and clinical symptoms in asthmatic subjects. J. Asthma, 41: 85-89.
    Direct Link  |  

  57. Riccioni, G., C.D. Ilio and N. D'Orazio, 2004. An update of the leukotriene modulators for the treatment of asthma. Exp. Opin. Invest. Drugs, 13: 763-776.
    CrossRef  |  Direct Link  |  

  58. Riccioni, G., C. di Ilio, P. Conti, T.C. Theoharides and N. D'Orazio, 2004. Advances in therapy with antileukotriene drugs. Ann. Clin. Lab. Sci., 34: 379-387.
    Direct Link  |  

  59. Riccioni, G., C. di Ilio and N. D'Orazio, 2004. Pharmacological treatment of airway remodeling: Inhaled corticosteroids or antileukotrienes? Ann. Clin. Lab. Sci., 34: 138-142.
    Direct Link  |  

  60. Kempuraj, D., J. Donelan, S. Frydas, T. Iezzi and F. Conti et al., 2004. Interleukin-28 and 29 (IL-28 and IL-29): New cytokines with Anti-viral activities. Int. J. Immunopathol. Pharmacol., 17: 103-106.
    PubMed  |  

  61. Kempuraj, D., C. Petrarca, S. Frydas, G. Riccioni, P. Conti, S. Tete and J. Vecchiet, 2004. Rat peritoneal mast cells release regulated upon activation normal T cell expressed and secreted (RANTES) after TNF-alpha activation. J. Biol. Regulators Homeostatic Agents, 19: 130-135.
    PubMed  |  

  62. Huang, S.H., S. Frydas, P. Conti, D. Kempuraj and R.C. Barbacane et al., 2004. Interleukin-17: A revisited study. Int. J. Immunopathol. Pharmacol., 17: 1-4.
    PubMed  |  

  63. Huang, S.H., S. Frydas, D. Kempuraj, R.C. Barbacane and A. Grilli et al., 2004. Interleukin-17 and the Interleukin-17 family member network. Allergy Asthma Proc., 25: 17-21.
    Direct Link  |  

  64. Frydas, S., T. Iezzi, D. Kempurai, W. Boucher and N.G. Papadoupolou et al., 2004. Human genome project and parasitic infections. Eur. J. Inflammation, 1: 1-4.

  65. Riccioni, G., S. Sensi, E. Ballone, M.T. Guagnano and R. Della Vecchia, 2003. Bronchial hyperresponsiveness, age, sex, sigarette smoke and quality of life in asthmatic subjects. Gior. Mal. Tor., 57: 116-123.

  66. Riccioni, G., R.D. Vecchia, N. D'Orazio, S. Sensi and M.T. Guagnano, 2003. Comparison of montelukast and budesonide on bronchial reactivity in subjects with Mild-moderate persistent asthma. Pulmonary Pharmacol. Ther., 16: 111-114.
    CrossRef  |  Direct Link  |  

  67. Riccioni, G., R. Della Vecchia, V. Menna, M.S. Lambo, C. di Ilio, N. D'Orazio, 2003. Gli antileucotrienici nella terapia dell'asma bronchiale. Rec. Prog. Med., 94: 509-515.

  68. Riccioni, G., R. Della Vecchia, M.T. Guagnano and N. D'Orazio, 2003. Asthma of the gut: Dream or reality? Eur. J. Clin. Invest., 33: 733-734.
    CrossRef  |  PubMed  |  

  69. Riccioni, G., N. D'Orazio, V. Menna, M. Lambo, MT Guagnano and C. di Ilio, 2003. The role of leptina in nervosa anorexia. Clin. Ter., 154: 401-404.

  70. Riccioni, G., N. D'Orazio, V. Menna and A. de Lorenzo, 2003. Fat soluble vitamins and immune system: An overview. Eur. J. Infl., 2: 59-64.

  71. Riccioni, G., N. D'Orazio, R. Della Vecchia and C. di Ilio, 2003. Remodelling and inflammation in bronchial asthma. Eur. J. Infl., 1: 9-12.

  72. Riccioni, G., N. D'Orazio, C. di Ilio, R. Della Vecchia, E. Ballone, V. Menna and M.T. Guagnano, 2003. Bronchial hyperresponsiveness and quality of life in asthmatic subjects. Respiration, 70: 496-499.

  73. Riccioni, G., A. de Santis, V. Cerasa, V. Menna and C. di Ilio et al., 2003. Atherosclerotic plaque formation and risk factors. Int. J. Immunopathol. Pharmacol., 16: 25-31.
    PubMed  |  

  74. Kempurai, D., S. Frydas, K. Kandere, B. Madhappan, R. Letorneau et al., 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol., 16: 95-97.

  75. Huang, S.H., F. Gambi, F. Conti, G. Carratelli and C.M. Conti et al., 2003. Antiepileptic drugs lower contraceptive sex hormone and increase the risk of unplanned pregnancies in women with epilepsy: Revisited study. Int. J. Immunopathol. Pharmacol., 16: 181-183.
    PubMed  |  

  76. Guagnano, M.T., M.R. Manigrasso, E. Ballone, R. Della Vecchia and G. Riccioni et al., 2003. Association between serum leptin levels and 24-hour blood pressure in obese women. Obesity Res., 11: 549-555.
    CrossRef  |  

  77. Frydas, S., M. Papazahariadou, N. Papaioannou, M. Hatzistilianou and M. Trakatellis et al., 2003. Effect of the compound L-mimosine in an in vivo model of chronic granuloma formation induced by potassium permanganate (KMNO4). Int. J. Immunopathol. Pharmacol., 16: 99-104.
    PubMed  |  

  78. Frydas, S., M. Hatzistilianou, B. Madhappan, N. D'Orazio, G. Riccioni, P. Conti and D. Kempurai, 2003. Chemokines and parasites. Int. J. Immunopathol. Pharmacol., 16: 221-224.

  79. Riccioni, G., R. Della Vecchia, M. Castronuovo, V. di Pietro and R. Spoltore et al., 2002. Bronchial hyperresponsiveness in adults with seasonal and perennial rhinitis: Is there a link for asthma and rhinitis? Int. J. Immunopathol. Pharmacol., 15: 69-74.
    PubMed  |  

  80. Riccioni, G., N. D'Orazio, C. di Ilio, R. Della Vecchia and A. de Lorenzo, 2002. Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma. Clin. Ter., 153: 317-321.
    PubMed  |  

  81. Riccioni, G., F. Santilli, N. D'Orazio, S. Sensi and R. Spoltore et al., 2002. The role of antileukotrienes in the treatment of asthma. Int. J. Immunopathol. Pharmacol., 15: 171-182.
    PubMed  |  

  82. Riccioni, G., E. Ballone, N. D'Orazio, S. Sensi and M. di Nicola et al., 2002. Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with Mild-persistent asthma. Int. J. Immunopathol. Pharmacol., 15: 149-155.
    PubMed  |  

  83. D'Orazio, N., C. Ficoneri, G. Riccioni, P. Conti, T.C. Theoharides and M.R. Bollea, 2002. Conjugated linoleic acid: A functional food? Int. J. Immunopathol. Pharmacol., 16: 215-220.
    Direct Link  |  

  84. Riccioni, G., F. di Stefano, M. de Benedictis, N. Verna and E. Cavallucci et al., 2001. Seasonal variability of Non-specific bronchial responsiveness in asthmatic patients with allergy to house dust mites. Allergy Asthma Proc., 22: 5-9.
    CrossRef  |  Direct Link  |  

  85. Guagnano, M.T., E. Ballone, V. Colagrande, R. Della Vecchia and M.R. Manigrasso et al., 2001. Large waist circumference and risk of hypertension. Int. J. Obesity Related Metab. Disorders: J. Int. Assoc. Study Obesity, 25: 1360-1364.
    CrossRef  |  Direct Link  |  

  86. Di Gioacchino, M., E. Cavallucci, F. di Stefano, F. Paolini and S. Ramondo et al., 2001. Effect of natural allergen exposure on Non-specific bronchial reactivity in asthmatic farmers. Sci. Total Environ., 270: 43-48.
    CrossRef  |  Direct Link  |  

  87. Riccioni, G., M. Castronuovo, M. de Benedictis, V. Pace-Palitti and M. di Gioacchino et al., 2000. Zafirlukast versus budesonide on bronchial reactivity in subjects with Mild-persistent asthma. Int. J. Immunopathol. Pharmacol., 14: 87-92.
    Direct Link  |  

  88. Di Gioacchino, M., E. Cavallucci, F. di Stefano, N. Verna and S. Ramondo et al., 2000. Influence of total IgE and seasonal increase of eosinophil cationic protein on bronchial hyperreactivity in asthmatic Grass-sensitized farmers. Allergy, 55: 1030-1034.
    CrossRef  |  Direct Link  |